Lung tissue of patients who suffered severely from COVID-19 shows good recovery in most cases. This was revealed by a study carried out by the Radboudumc that has now been published in Clinical Infectious Diseases. A striking conclusion is that the group who were referred by a GP did not recover as well as patients who were admitted to the hospital’s Intensive Care Unit (ICU).
The study, led by pulmonologist Bram van den Borst, included 124 patients who had recovered from acute COVID-19 infections. They visited the Radboudumc corona aftercare clinic. The patients were examined by CT scan, a lung functional test and more. After three months, the researchers took stock, which revealed that the patients’ lung tissue is recovering well. Residual damage in the lung tissue was generally limited and is most often seen in patients who were treated in the ICU. The most common complaints after three months are fatigue, shortness of breath and chest pains. Many people also still experience limitations in their daily life as well as a decreased quality of life. Main researcher and pulmonologist Bram van den Borst explains: “The patterns we see in these patients show similarities with recovery after acute pneumonia or acute respiratory distress syndrome (ARDS), in which fluid accumulates in the lungs. Recovery from these conditions also generally takes a long time. It is encouraging to see that lungs after COVID-19 infections exhibit this level of recovery.”
Referred patients do not recover as well as admitted patients
Patients were divided into three categories for the study: a group with patients who were admitted to the ICU, a group of patients who were admitted to a nursing ward in the hospital, and finally a group with patients who could stay home but experienced persisting symptoms that eventually warranted a referral from their GP.
The study assessed how patients fared after three months and revealed that the patients who were referred to the aftercare clinic by their GP showed the worse recovery in the following period. Of course, this latter group of patients was referred because of their persisting symptoms. “However, it does seem that there is a clear subgroup of patients who initially experienced mild COVID-19 symptoms and later kept experiencing persistent long-term complaints and limitations”, Bram van den Borst elaborates. “What is striking is that we barely found any anomalies in the lungs of these patients. Considering the variety and seriousness of the complaints and the plausible size of this subgroup, there is an urgent need for further research into explanations and treatment options.”
Aftercare clinic for patients with persisting symptoms
Radboudumc established the corona aftercare clinic at the Dekkerswald location as a reaction to an observed increase in the signals that a substantial number of COVID-19 patients was experiencing long-term complaints, ranging from coughing, fatigue and shortness of breath to anxiety and physical limitations. At the aftercare clinic, an extensive analysis is performed involving multiple disciplines. Based on this analysis, the care requirements of the patients and the subsequent steps are determined. Patients who were admitted at Radboudumc with COVID-19 will receive an invitation from the corona aftercare clinic. People who went through COVID-19 from home and are still experiencing symptoms can get a referral from their GP to visit the aftercare clinic as well.
About the publication
Publication in Clinical Infectious Disease: Comprehensive health assessment three months after recovery from acute COVID-19 – Bram van den Borst, Jeannette B. Peters, Monique Brink, Yvonne Schoon, Chantal P. Bleeker-Rovers, Henk Schers, Hieronymus W.H. van Hees, Hanneke van Helvoort, Mark van den Boogaard, Hans van der Hoeven, Monique H. Reijers, Mathias Prokop, Jan Vercoulen, Michel van den Heuvel.
Related news items
Increase radio- and immunotherapy efficacy by targeting hypoxia21 January 2021
In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.read more
Radiation boost lowers risk of prostate cancer recurrence21 January 2021
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.read more
New research through grants for Radboudumc researchers14 January 2021
Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.read more
RIMLS online award ceremony proudly presenting the winners13 January 2021
In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.read more
Cooling vests alleviate perceptual heat strain perceived by COVID-19 nurses11 January 2021
Wearing cooling vests during a COVID-19 shift ensures that nurses experience less heat during their work. The cooling vests offer such effective cooling that they are now part of the standard work clothing for nurses in the COVID nursing departments at Radboudumc.read more